Baystreet Staff - Thursday, November 17, 2011 Amorfix Life Sciences 11:53 AM EST - Amorfix Life Sciences : announced that the Company is developing a blood test to be used as a diagnostic tool for amyotrophic lateral sclerosis (ALS). Amorfix Life Sciences shares T.AMF are trading down $0.005 at $0.20.